Worth Venture Partners, LLC Amgen Inc Transaction History

Worth Venture Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.09 Million - $2.45 Million	-12,548 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $2.27 Million - $2.56 Million	12,548 New	12,548 $2.38 Million

3,173

419M

8.25M

6.39M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.